Aug 2026· Analytical Methods· Vol 18, pp. 8394-8401· 0 citations· 34 references
Medicine
TL;DR
It is proposed that analysing permeation of novel pharmaceutical compounds using the DPPC-coated PDMS can help researchers predict BBB permeation using an in vitro technique thus facilitating prediction and helping understand drug behaviour in the body.
Abstract
Blood-brain barrier (BBB) permeability of drugs is fundamental to understand yet incredibly difficult to measure, or even, predict. This study proposes the adoption of a chemically modified form of poly(dimethylsiloxane) (PDMS) as an in vitro biomedical mimic of the BBB for pharmaceutical analysis. Initially, a series of untreated PDMS membrane thicknesses (0.02 to 0.4 mm) were studied to review the permeation of 15 model compounds to ultimately select the most suitable material for further modification. This was deemed to be 0.2 mm for maximising permeability range, maintaining experimental ease of use and also similarity to in vivo BBB thickness. Five distinct membranes were then created and subsequently analysed with the same 15 compounds to determine the most suitable BBB mimic through correlation with literature data. Ultimately, a strong correlation was found between published BBB values and cumulative permeation through the hydrophobic DPPC-coated form of PDMS (r2 = 0.75) based on its similarity to the lipid-rich BBB environment. This then facilitated prediction of BBB values for compounds where no literature data has ever been listed. It is proposed that analysing permeation of novel pharmaceutical compounds using the DPPC-coated PDMS can help researchers predict BBB permeation using an in vitro technique thus facilitating prediction and helping understand drug behaviour in the body.
Background/Objectives: The permeation behavior of new drug candidates for central nervous system (CNS) diseases is a major bottleneck in drug development. Thus, using a meaningful in vitro blood–brain barrier (BBB) model in the preclinical phase to determine cerebral drug bioavailability is crucial. However, due to the...
Verena Ledwig, T. May, Andreas Dietzel et al.· Biomedicines· 0 citations
Lipophilicity shows a saturating relationship with skin permeability that a linear equation cannot represent, and interpolation within the sampled chemical space does not imply generalisation to a new therapeutic class.
BACKGROUND
Predicting blood-brain barrier (BBB) permeability remains a central problem in central nervous system (CNS) drug design. Conventional rules such as Lipinski's rule of five and related CNS guidelines describe physicochemical boundaries but do not guarantee permeability.
OBJECTIVE
We examined how a set of mo...
Tatsuki Onishi· European Journal of Pharmace...· 0 citations
An integrated platform linking molecular structure, physicochemical properties, and BBB permeability to support the rational evaluation and prioritisation of compounds within the investigated KYNA derivative series is established.
Zahraa Ali, Bálint Lőrinczi, Péter Simon et al.· European Journal of Pharmace...· 0 citations
Background: Neurodegenerative diseases (NDDs) impose a growing burden, yet effective therapy remains limited because the blood–brain barrier (BBB) restricts CNS drug delivery. Existing reviews treat particle geometry as secondary to composition, size, and surface functionalization. Objectives: This review examines shap...
Background/Objectives: The blood–brain barrier (BBB) is compromised in many neurological disorders, yet in vitro models rarely reproduce graded inflammatory stimulation of brain endothelial cells in vivo. This study developed a detachable, modular BBB-on-a-chip for stepwise inflammation modeling with multi-marker reado...